Literature DB >> 5883119

Influence of blood and serum on the antistaphylococcal activity of lysostaphin.

W A Sygmunt, H P Browder, P A Tavormina.   

Abstract

Zygmunt, Walter A. (Mead Johnson & Co., Evansville, Ind.), Henry P. Browder, and Peter A. Tavormina. Influence of blood and serum on the antistaphylococcal activity of lysostaphin. J. Bacteriol. 91:725-728. 1966.-Human and animal sera, and in certain instances whole blood, exhibited a minimal antagonizing effect on the antistaphylococcal activity of lysostaphin. The presence of 50% human serum only temporarily inhibited cell lysis of viable suspensions of Staphylococcus aureus by lysostaphin. The results obtained on the recovery of viable cells after exposure of S. aureus to lysostaphin actually suggest an enhancement of the antistaphylococcal activity of the antibiotic in the presence of 50% human serum. The growth-inhibitory activity of the antibiotic against 30 clinical isolates of S. aureus was only slightly depressed by the presence of 25% bovine plasma. The data suggest that some binding may occur between the antibiotic and serum proteins, but it is not of an irreversible type. Lysostaphin does not bind readily to red blood cells nor does it enter these cells to any significant degree.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5883119      PMCID: PMC314920          DOI: 10.1128/jb.91.2.725-728.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  LYSOSTAPHIN THERAPY IN MICE INFECTED WITH STAPHYLOCOCCUS AUREUS.

Authors:  V T SCHUHARDT; C A SCHINDLER
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

2.  LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.

Authors:  C A SCHINDLER; V T SCHUHARDT
Journal:  Proc Natl Acad Sci U S A       Date:  1964-03       Impact factor: 11.205

3.  THE IN VITRO EFFECT OF LYSOSTAPHIN ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS.

Authors:  C B CROPP; E F HARRISON
Journal:  Can J Microbiol       Date:  1964-12       Impact factor: 2.419

4.  LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.

Authors:  H P BROWDER; W A ZYGMUNT; J R YOUNG; P A TAVORMINA
Journal:  Biochem Biophys Res Commun       Date:  1965-04-23       Impact factor: 3.575

5.  MICROBIOLOGICAL ACTIVITIES OF LYSOSTAPHIN AND PENICILLINS AGAINST BACTERIOPHAGE 80/81 STRAINS OF STAPHYLOCOCCUS AUREUS.

Authors:  W A ZYGMUNT; E F HARRISON; H P BROWDER
Journal:  Appl Microbiol       Date:  1965-05

6.  COMPARATIVE IN VITRO ACTIVITIES OF LYSOSTAPHIN AND OTHER ANTISTAPHYLOCOCCAL ANTIBIOTICS ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS.

Authors:  E F HARRISON; C B CROPP
Journal:  Appl Microbiol       Date:  1965-03
  6 in total
  4 in total

1.  Efficacy of Novel Antistaphylococcal Ectolysin P128 in a Rat Model of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  Shankaramurthy Channabasappa; Murali Durgaiah; Ravisha Chikkamadaiah; Senthil Kumar; Amruta Joshi; Bharathi Sriram
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  [Studies with lysotaphin. II. Lysostaphin sensitivity of 230 strains of Staph. aureus of animal origin].

Authors:  G Pulverer
Journal:  Z Med Mikrobiol Immunol       Date:  1968

3.  Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics.

Authors:  Yongliang Fang; Jack R Kirsch; Liang Li; Seth A Brooks; Spencer Heim; Cynthia Tan; Susan Eszterhas; Hao D Cheng; Hongliang Zhao; Yan Q Xiong; Karl E Griswold
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

4.  Biochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128.

Authors:  Shilpa E George; Ravisha Chikkamadaiah; Murali Durgaiah; Amruta A Joshi; Ullas P Thankappan; Shampur N Madhusudhana; Bharathi Sriram
Journal:  BMC Res Notes       Date:  2012-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.